90 related articles for article (PubMed ID: 2953084)
1. [Comparative characteristics of adenosine triphosphatase activity in the erythrocytes of patients with acute and chronic liver diseases, chronic cholecystitis and in HBs antigen carriers].
Makarenko EV; Kozlovskiĭ IV
Ter Arkh; 1987; 59(2):98-100. PubMed ID: 2953084
[TBL] [Abstract][Full Text] [Related]
2. [Lactate dehydrogenase, glucosephosphate dehydrogenase, glutathione reductase and adenosine triphosphatase activities in the erythrocytes of patients with acute viral hepatitis].
Martynov VA; Kolobaev VI
Ter Arkh; 1987; 59(2):94-7. PubMed ID: 2953083
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic significance of erythrocyte carbohydrate metabolism indicators in chronic subclinical HBsAG carrier state].
Levina LD; Bezuglova IA; Proĭdakov MA
Klin Med (Mosk); 1995; 73(6):26-8. PubMed ID: 8691773
[TBL] [Abstract][Full Text] [Related]
4. [ATPase activity of erythrocytes in chronic diseases of the liver and stomach].
Makarenko EV
Lab Delo; 1987; (2):14-7. PubMed ID: 2437360
[No Abstract] [Full Text] [Related]
5. Laparoscopical and histological abnormalities of the liver in chronic HBs ag (hepatitis B surface antigen) carriers.
Iwamura K
Tokai J Exp Clin Med; 1982 Jan; 7(1):43-51. PubMed ID: 6210975
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic an histologic abnormalities of the liver in chronic asymptomatic hepatitis B surface antigen carriers.
Iwamura K
Tokai J Exp Clin Med; 1981 Oct; 6(4):385-91. PubMed ID: 7324079
[TBL] [Abstract][Full Text] [Related]
7. [Differential, diagnostic value of determination of total ATPase in the erythrocytes in acute and chronic viral hepatitis, liver cirrhosis and obstructive jaundice].
Bochkova LM; Voronova GV
Ter Arkh; 1980; 52(11):45-7. PubMed ID: 6451043
[No Abstract] [Full Text] [Related]
8. Chronic asymptomatic HBSAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV.
De Franchis R; D'Arminio A; Vecchi M; Ronchi G; Del Ninno E; Parravicini A; Ferroni P; Zanetti AR
Gastroenterology; 1980 Sep; 79(3):521-7. PubMed ID: 7429112
[TBL] [Abstract][Full Text] [Related]
9. [Effect of hemodialysis on erythrocyte acetylcholinesterase and adenosine triphosphatase activity in chronic renal insufficiency].
Kulikova AI; Romanchuk LA; Tugusheva FA; Chuprasov VB; Shostka GD
Vopr Med Khim; 1979; 25(3):268-72. PubMed ID: 222070
[TBL] [Abstract][Full Text] [Related]
10. [2-year follow-up of a series of cases of asymptomatic carriers of HBsAg antigen].
Menicagli V
Arch Sci Med (Torino); 1982; 139(1):99-104. PubMed ID: 7103714
[TBL] [Abstract][Full Text] [Related]
11. [Hepatitis B viral markers in the liver tissue of HBs-antigen carriers].
Mansurov KhKh; Mirodzhov GK; Tkalicheva LI
Arkh Patol; 1984; 46(4):46-51. PubMed ID: 6375639
[TBL] [Abstract][Full Text] [Related]
12. [The cytochemical determination of alpha-glycerophosphate dehydrogenase and adenosine triphosphatase in the peripheral blood lymphocytes of patients with hepatobiliary system pathology].
Podil'chak MD; Makar DA; Terlets'ka LM
Klin Khir (1962); 1994; (9):22-4. PubMed ID: 7602937
[TBL] [Abstract][Full Text] [Related]
13. [Echohepatographic data on chronic HBs-antigen carriers].
Postovit NV
Vrach Delo; 1982 Apr; (4):109-11. PubMed ID: 7101843
[No Abstract] [Full Text] [Related]
14. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
[TBL] [Abstract][Full Text] [Related]
15. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
[TBL] [Abstract][Full Text] [Related]
16. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
[TBL] [Abstract][Full Text] [Related]
17. [HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study].
Perret JL; Moussavou-Kombila JB; Delaporte E; Pemba LF; Boguikouma JB; Matton T; Larouze B
Gastroenterol Clin Biol; 2002 Feb; 26(2):131-5. PubMed ID: 11938063
[TBL] [Abstract][Full Text] [Related]
18. [Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].
Zhu F; Ning Q; Chen Y; Tao XX; Yan WM; Xi D; Yan FM; Hao LJ; Luo XP
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):385-8. PubMed ID: 15268797
[TBL] [Abstract][Full Text] [Related]
19. Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis.
Colombo M; Cambieri R; Rumi MG; Ronchi G; Del Ninno E; De Franchis R
Gastroenterology; 1983 Aug; 85(2):235-9. PubMed ID: 6345255
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis B e antigen in pregnant women and patients with liver disease.
Gill HH; Majumdar PD; Dhunjibhoy KR; Desai HG
J Assoc Physicians India; 1995 Apr; 43(4):247-8. PubMed ID: 8713262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
